Alliance for Clinical Trials in Oncology Mar 13 2026 Immunotherapy given during and after chemoradiation did not improve survival for study participants with limited-stage, small-cell lung cancer (SCLC) according to the results of an international clinical trial, NRG-LU005, led by NRG Oncology in collaboration with the Alliance for Clinical Trials in Oncology. The results are published in the  Journal of Clinical Oncology. The trial did not meet its primary endpoint as the addition of the